Home / Health / Reality Star Slams "Everyone" on Ozempic
Reality Star Slams "Everyone" on Ozempic
12 Mar
Summary
- Brianna LaPaglia criticizes widespread Ozempic use for weight loss.
- GLP-1 drug use doubled between 2024 and 2025, survey shows.
- Lawsuits allege manufacturers didn't warn of severe drug risks.
Brianna "Chickenfry" LaPaglia has voiced strong criticism regarding the escalating use of weight-loss medications like Ozempic. The Barstool Sports personality expressed concern in a recent TikTok video that individuals who do not require the drug are using it, warning of potential dire consequences.
Data indicates a significant surge in GLP-1 drug consumption in the U.S., with usage more than doubling between 2024 and 2025 according to a Gallup survey. These drugs, approved for weight loss in 2021, are popular for their effectiveness in shedding pounds and promoting satiety.
However, these medications are associated with several side effects, ranging from nausea and constipation to more severe issues like pancreatitis and hair thinning. Manufacturers, including Novo Nordisk and Eli Lilly, are currently facing thousands of lawsuits alleging failure to sufficiently warn about these risks.
Amidst LaPaglia's critique, other public figures, including co-hosts of "The View" and celebrities like Serena Williams and Oprah Winfrey, have openly discussed their positive experiences with GLP-1 drugs, highlighting their effectiveness in achieving healthy weight goals and improving overall well-being.
